Literature DB >> 3141284

Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro.

D P Krieg1, R J Helmke, V F German, J A Mangos.   

Abstract

A unique, recently described rat alveolar macrophage cell line (NR8383) was used to study the interaction of the pulmonary immune system with a mucoid cystic fibrosis isolate of Pseudomonas aeruginosa (SRM-3), its nonmucoid revertant (SRM-3R), and a non-cystic fibrosis isolate (PAO-1). Strain SRM-3 was cultivated in a chemostat system to allow maintenance of an entirely mucoid population. The alveolar macrophage response to the mucoid and nonmucoid strains of P. aeruginosa was determined by visually quantitating phagocytosis in acridine orange-stained monolayers and measuring the induction of an oxidative burst as indicated by chemiluminescence and H2O2 production. In all experiments, fewer than 2% of the NR8383 cells engulfed the mucoid SRM-3 isolate, while SRM-3R and PAO-1 were phagocytized by 15 and 41%, respectively. Opsonization by normal serum (complement) provided minimal phagocytic enhancement of these strains, whereas specific anti-P. aeruginosa antibody slightly elevated phagocytic responses to strains with nonmucoid phenotypes while providing a sevenfold increase in uptake of SRM-3. Chemiluminescent and H2O2 responses were comparable with the levels of phagocytosis observed, with very little or no response to the mucoid strain SRM-3. The data indicate that the strains with mucoid phenotypes are refractile to ingestion and that studies which describe ingestion of mucoid strains were likely measuring ingestion of revertants. Alginic acid (2 mg/ml) was found to inhibit stimulation of macrophage response to the opsonized and unopsonized nonmucoid strain PAO-1.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141284      PMCID: PMC259720          DOI: 10.1128/iai.56.12.3173-3179.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

2.  Assessment of blood leukocyte microbial killing by using a new fluorochrome microassay.

Authors:  C G Pantazis; W T Kniker
Journal:  J Reticuloendothel Soc       Date:  1979-08

3.  A simple method for the detection and quantitative determination of hexuronic acids and pentoses.

Authors:  A H Wardi; W S Allen; R Varma
Journal:  Anal Biochem       Date:  1974-01       Impact factor: 3.365

4.  A macrophage receptor for (mannose/glucosamine)-glycoproteins of potential importance in phagocytic activity.

Authors:  G A Warr
Journal:  Biochem Biophys Res Commun       Date:  1980-04-14       Impact factor: 3.575

5.  Differences between particulate and peptide stimuli on activation of oxidant production in alveolar macrophages.

Authors:  G E Hatch; A Spock; D E Gardner; D B Menzel
Journal:  Chest       Date:  1980-02       Impact factor: 9.410

6.  Chemiluminescence by polymorphonuclear leukocytes adhering to surfaces.

Authors:  M Yanai; P G Quie
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

7.  Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.

Authors:  H Y Reynolds; J A Kazmierowski; H H Newball
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

8.  Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide.

Authors:  P Ames; D DesJardins; G B Pier
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

9.  Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa.

Authors:  L R Evans; A Linker
Journal:  J Bacteriol       Date:  1973-11       Impact factor: 3.490

10.  Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages.

Authors:  D A Cabral; B A Loh; D P Speert
Journal:  Pediatr Res       Date:  1987-10       Impact factor: 3.756

View more
  25 in total

1.  Role of energy metabolism in conversion of nonmucoid Pseudomonas aeruginosa to the mucoid phenotype.

Authors:  J M Terry; S E Piña; S J Mattingly
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

2.  Global genomic analysis of AlgU (sigma(E))-dependent promoters (sigmulon) in Pseudomonas aeruginosa and implications for inflammatory processes in cystic fibrosis.

Authors:  Aaron M Firoved; J Cliff Boucher; Vojo Deretic
Journal:  J Bacteriol       Date:  2002-02       Impact factor: 3.490

Review 3.  What's on the Outside Matters: The Role of the Extracellular Polymeric Substance of Gram-negative Biofilms in Evading Host Immunity and as a Target for Therapeutic Intervention.

Authors:  John S Gunn; Lauren O Bakaletz; Daniel J Wozniak
Journal:  J Biol Chem       Date:  2016-04-21       Impact factor: 5.157

Review 4.  Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Authors:  Eric Wenzler; Dustin R Fraidenburg; Tonya Scardina; Larry H Danziger
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

5.  Functional characterization of recombinant rat macrophage inflammatory protein-1 alpha and mRNA expression in pulmonary inflammation.

Authors:  M M Shi; I W Chong; N C Long; J A Love; J J Godleski; J D Paulauskis
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

6.  Pseudomonas aeruginosa selective adherence to and entry into human endothelial cells.

Authors:  M C Plotkowski; A M Saliba; S H Pereira; M P Cervante; O Bajolet-Laudinat
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa.

Authors:  Aaron M Firoved; Vojo Deretic
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

Review 8.  Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa.

Authors:  Rustin R Lovewell; Yash R Patankar; Brent Berwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-24       Impact factor: 5.464

9.  Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis.

Authors:  E Mahenthiralingam; M E Campbell; D P Speert
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

Review 10.  Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.

Authors:  T B May; D Shinabarger; R Maharaj; J Kato; L Chu; J D DeVault; S Roychoudhury; N A Zielinski; A Berry; R K Rothmel
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.